
RYAN Stock Forecast & Price Target
RYAN Analyst Ratings
Bulls say
Ryan Specialty Holdings is in a strong position as a critical intermediary in the specialty insurance market, with historically strong organic growth outpacing its large-cap peers. While the overall specialty market has been experiencing a deceleration in P&C pricing, the company's "Empower" restructuring program and shift towards buybacks demonstrate a commitment to streamlining operations and supporting future margin expansion. Though organic growth may dip in the near term, the company remains well-positioned for long-term success.
Bears say
Ryan Specialty Holdings is facing a challenging market environment, with declining rates and increased competition across its major product categories. This has resulted in lower-than-expected organic growth and margins, and the company has lowered its guidance for 2026, with organic growth now expected to be only in the high single digits and adjusted EBITDAC margin to be flat to moderately down. In response to these challenges, the company has launched a restructuring program aimed at streamlining operations, optimizing scale, and accelerating its data and technology strategies. However, this program is expected to incur a significant charge and may take time to deliver results, further adding to the company's uncertainties. With the current market conditions and competitive landscape, it may be difficult for Ryan Specialty Holdings to meet its growth and profitability targets in the near future, leading to a negative outlook for its stock.
This aggregate rating is based on analysts' research of Ryan Specialty Group Holdings and is not a guaranteed prediction by Public.com or investment advice.
RYAN Analyst Forecast & Price Prediction
Start investing in RYAN
Order type
Buy in
Order amount
Est. shares
0 shares